Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Lafitte

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Preventive Cardiology|November 2, 2013
Education and home based training for intermittent claudication: functional effects and quality of lifeAlain Prévost, Marianne Lafitte, Yann Pucheu, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2014
Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugsKarin Martin-Latry, Julie Cazaux, Marianne Lafitte, et al.
European Journal of Preventive Cardiology|September 9, 2011
Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatmentMélanie Riedel, Marianne Lafitte, Yann Pucheu, et al.
European Heart Journal|November 11, 2008
Cerebral embolism from subclinical carotid atherosclerotic lesion in a young woman with inflammatory Crohn diseaseMarianne Lafitte, Sabrina Debruxelles, Igor Sibon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2012
Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement databasePhilippe Latry, Karin Martin-Latry, Marianne Lafitte, et al.
European Journal of Preventive Cardiology|February 21, 2012
Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndromeMarianne Lafitte, Yann Pucheu, Karin Latry, et al.
Vascular Health and Risk Management|June 16, 2012
Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiencyJulia Savel, Marianne Lafitte, Yann Pucheu, et al.
Archives of Cardiovascular Diseases|March 16, 2010
After acute coronary syndrome, diabetic patients with peripheral vascular disease remain at high risk of cardiovascular events despite secondary prevention measuresMarianne Lafitte, Laurent Barandon, Yann Pucheu, et al.
Journal of the American College of Cardiology|March 21, 2006
Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathyKarim Serri, Patricia Reant, Marianne Lafitte, et al.
The American Journal of Cardiology|November 28, 2006
Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significanceCarine Boulon, Marianne Lafitte, Vincent Richeboeuf, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Preventive Cardiology|November 2, 2013
Education and home based training for intermittent claudication: functional effects and quality of lifeAlain Prévost, Marianne Lafitte, Yann Pucheu, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2014
Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugsKarin Martin-Latry, Julie Cazaux, Marianne Lafitte, et al.
European Journal of Preventive Cardiology|September 9, 2011
Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatmentMélanie Riedel, Marianne Lafitte, Yann Pucheu, et al.
European Heart Journal|November 11, 2008
Cerebral embolism from subclinical carotid atherosclerotic lesion in a young woman with inflammatory Crohn diseaseMarianne Lafitte, Sabrina Debruxelles, Igor Sibon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2012
Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement databasePhilippe Latry, Karin Martin-Latry, Marianne Lafitte, et al.
European Journal of Preventive Cardiology|February 21, 2012
Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndromeMarianne Lafitte, Yann Pucheu, Karin Latry, et al.
Vascular Health and Risk Management|June 16, 2012
Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiencyJulia Savel, Marianne Lafitte, Yann Pucheu, et al.
Archives of Cardiovascular Diseases|March 16, 2010
After acute coronary syndrome, diabetic patients with peripheral vascular disease remain at high risk of cardiovascular events despite secondary prevention measuresMarianne Lafitte, Laurent Barandon, Yann Pucheu, et al.
Journal of the American College of Cardiology|March 21, 2006
Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathyKarim Serri, Patricia Reant, Marianne Lafitte, et al.
The American Journal of Cardiology|November 28, 2006
Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significanceCarine Boulon, Marianne Lafitte, Vincent Richeboeuf, et al.
Pageof 2